Challenging Settings Facing Cervical Cancer Tumour Boards in Limited Resources Settings, 8 Years Experience

ESGO eAcademy, Olga P. Matylevich, 4151761

The Role of Surgery and Indication

ESGO eAcademy, Nicolo Bizzarri, 4151750

Immediate Lymphatic Reconstruction At Time Of Inguinofemoral Lymphadenectomy For Patients With Vulvar Cancer

ESGO eAcademy, Maureen Byrne, 4151743

Treatment of Cervical Cancer: ICIS and Beyond

ESGO eAcademy, Nicoletta Colombo, 4151746

Image-Guided Robotic Surgery For Sentinel Lymph Node Status Assessment In Uterine Cancers Using Ultrasound Drop-In Probe: Surgical Technique In 10 Steps

ESGO eAcademy, Matteo Pavone, 4151742

Urethral Neovestibule Reconstruction After Ultraradical Vulvar Surgery: The Gemelli Technique

ESGO eAcademy, Sara Ammar, 4151741

Durvalumab plus Carboplatin/Paclitaxel Followed by Durvalumab with or without Olaparib as First-Line Treatment for Endometrial Cancer: Patient-Reported Outcomes in the DUO-E/GOG-3041/ENGOT-EN10 Intent-To-Treat Population and by Mismatch Repair Status

ESGO eAcademy, Larissa Meyer, 4151737

What’s New in Ovarian Cancer?

ESGO eAcademy, Jonathan Ledermann, 4151745

Gyn-Twin Study: 3D Digital Twin For Precision Surgery In Gynecological Neoplasms

ESGO eAcademy, Andrea Rosati, 4151740

Pembrolizumab Or Placebo Plus Adjuvant Chemotherapy With Or Without Radiotherapy In Patients With Newly Diagnosed, High-Risk Endometrial Cancer: Exploratory Analysis Of Disease-Specific Survival From The Phase 3 ENGOT-En11/GOG-3053/KEYNOTE-B21 Study

ESGO eAcademy, Toon Van Gorp, 4151736

New Advances in Endometrial Cancer

ESGO eAcademy, Amanda Fader, 4151744

Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study

ESGO eAcademy, Giorgio Valabrega, 4151735

Considerations for Patients Receiving ADCs in the Platinum-Resistant Setting

ESGO eAcademy, Jose Alejandro Perez-Fidalgo, 4151721

ADC-Based Treatment Strategies: Benefits and Drawbacks of Different Antibodies and Linkers, How to Manage Treatment Sequencing

ESGO eAcademy, Isabelle Ray-Coquard, 4151720

Biology of the Disease, Testing Considerations, Current and Emerging Therapies

ESGO eAcademy, Ilaria Colombo, 4151719

Metastatic and Recurrent Disease

ESGO eAcademy, Nicoletta Colombo, 4151701

Adjuvant Therapy: The Guide for Daily Clinical Decision-Making on Whom and How

ESGO eAcademy, Antonio Gonzalez Martin, 4151700

Prognostic Value Of Different Stages Of Maturation Of Tertiary Lymphoid Structures In Molecular Subgroups Of Endometrial Carcinoma

ESGO eAcademy, Manohar Pradhan, 4151717

Five Years Of Real-Life Data In Gynaecological Cancers: A Multicenter Clinical Registry With Associated Samples (GEICO 81-T)

ESGO eAcademy, Fernando Galvez-Montosa, 4151716

Concordance Of Molecular Class In Matched Primary And Metastatic Endometrial Cancer

ESGO eAcademy, Mari Halle, 4151715

Abdominal Cavity Collections

ESGO eAcademy, Santiago Domingo, 4151706

Surgical Cornerstones

ESGO eAcademy, Ignace Vergote, 4151699

Development And Validation Of An Endometrial Cancer Specific CtDNA Panel (ECctDNA) To Detect Cancer Recurrence

ESGO eAcademy, Esther Moss, 4151714

Hysterectomy Or Not For Borderline Ovarian Tumor In Menopause? Results From A National Multicenter Observational, Retrospective, Cohort Study

ESGO eAcademy, Manuela Maletta, 4151713

The Headache of the Anastomosis Leakage

ESGO eAcademy, Dennis Chi, 4151705

Predicting HRD Results In Patient With Ovarian Cancer Using Deep Learning Models On 40x Whole Slide Images

ESGO eAcademy, Ji Hyun Lee, 4151712

Molecular and Conventional Parameters for Classification

ESGO eAcademy, Sigurd Lax, 4151698

The Prognostic And Predictive Value Of Cardiophrenic Lymph Nodes In Patients Receiving Hyperthermic Intraperitoneal Chemotherapy For Ovarian Cancer In The OVHIPEC-1 Trial

ESGO eAcademy, Madelief Schreuder Goedheijt, 4151711

Diaphragm Complications

ESGO eAcademy, Alejandra Martinez, 4151704

Impact Of Adjuvant (Chemo)Radiation Therapy On Survival In Intermediate-Risk Early-Stage Cervical Cancer

ESGO eAcademy, Anna Norberg Hardie, 4151710

Surgical Site Complications (including SSI and Abdominal Wall Dehiscence)

ESGO eAcademy, Santiago Domingo, 4151703

Role Of Prophylactic HPV Vaccination In Patients With Cervical Cancer Treated With Fertility Sparing Surgery (CER-VAX 1 Study).

ESGO eAcademy, Nicolo Bizzarri, 4151709

Molecular Integrated Risk Group Stratification

ESGO eAcademy, Remi Nout, 4151697

Prophylactic Bilateral Salpingo-Oophorectomy With VNOTES: A New Era In Cancer Prevention Strategies

ESGO eAcademy, Maria Pellise Tintore, 4151708

Implementing High-Risk Human Papillomavirus Self-Sampling For Cervical Cancer Screening In Ghana: A Pilot Study (CarciSCAN)

ESGO eAcademy, Nadja Taumberger, 4151707

DVT/PE in the ERAS Era!

ESGO eAcademy, Alejandra Martinez, 4151702

Introduction to ESGO-ESTRO-ESP Updated Endometrial Cancer Guidelines (with ENGAGe)

ESGO eAcademy, Nicole Concin, 4151696

Immunotherapy Treatment Approaches for Locally Advanced Cervical Cancer

ESGO eAcademy, Gabriella Macchia, 4151684

How to Select the Best Treatment for Your Patients: From Science to Clinical Practice

ESGO eAcademy, Iain McNeish, 4151688

Endometrial Cancer: Exploring 1L Options for Non-dMMR Patients

ESGO eAcademy, Christian Marth, 4151682

Welcome and Introductions

ESGO eAcademy, Ramez Eskander, 4151681

EU -OSNA, A Multicentre European Diagnostic Performance Study Of One-Step Nucleic Acid Amplification Analysis Of Sentinel Lymphatic Nodes In Endometrial Cancer Patients

ESGO eAcademy, Jan Kostun, 4151680

Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab With/Without Olaparib In Endometrial Cancer: Exploratory Analyses Of Histology, Biomarker Heterogeneity And Efficacy In The DUO-E Mismatch Repair Proficient Subpopulation

ESGO eAcademy, Els Van Nieuwenhuysen, 4151679

Prognostic Significance Of Isolated Tumor Cells In Sentinel Lymph Nodes In Low- And Intermediate-Risk Endometrial Cancer Patients: Updated Results From An International Multi-Institutional Study.

ESGO eAcademy, Emilia Palmieri, 4151678

Added Prognostic Value Of Sentinel Lymph Node Mapping In Endometrial Cancer To Molecular Subgroups

ESGO eAcademy, Franziska Siegenthaler, 4151677

Is Immunotherapy in LACC for All? Any Other Alternative? And Which Combination for the Future?

ESGO eAcademy, Mansoor Raza Mirza, 4151673

Improving Endometrial Cancer Assessment By Combining The New TechniqUe Of GENomic Profiling With Surgical Extra UterIne DisEase Assessment (EUGENIE). Second Interim Analysis After Two Years Of Enrolment.

ESGO eAcademy, Rita Trozzi, 4151676

Time Course Of Adverse Events In Primary Advanced Or Recurrent Endometrial Cancer Treated With Dostarlimab Plus Chemotherapy In The ENGOT-EN-6-NSGO/GOG-3031/RUBY Trial

ESGO eAcademy, David Cibula, 4151675

Is there a Place for Immunotherapies in LACC?

ESGO eAcademy, Bradley J. Monk, 4151672

Artificial Intelligence-Based Models For Early Detection Of Endometrial Cancer And Atypical Hyperplasia From Transvaginal Ultrasound Images

ESGO eAcademy, Diletta Fumagalli, 4151674

4 new Algorithms in Rare Cancers

ESGO eAcademy, Richard Schwameis, 4151660

Immunotherapy and Other Hot News in GTN

ESGO eAcademy, Michael Seckl, 4151659

Novel Therapies in Rare Uterine Tumours

ESGO eAcademy, David Tan, 4151658

Clinical Case Study Illustrating the New ESGO-INCIP Guideline on Gynaecological Cancer During Pregnancy: Interactive session

ESGO eAcademy, Antonia Carla Testa, 4151661

Clinical Case Study Illustrating the New ESGO-INCIP Guideline on Gynaecological Cancer During Pregnancy: Interactive session

ESGO eAcademy, Michael Halaska, 4151662

Clinical Case Study Illustrating the New ESGO-INCIP Guideline on Gynaecological Cancer During Pregnancy: Interactive session

ESGO eAcademy, Frederic Amant, 4151663

Hot Topics in 2025 for Rare Ovarian Tumours

ESGO eAcademy, Isabelle Ray-Coquard, 4151657

Interval Debulking Surgery + HIPEC; Robotic-Assisted Radical Hysterectomy; Hysteroscopic Resection of Endometrial Cancer; V-note Approach for Low-risk Endometrial Cancer

ESGO eAcademy, Anna Fagotti, 4151653

"All Roads Lead to Rome" Historical Lecture

ESGO eAcademy, Costantino D’Orazio, 4151652

ESGO Database Project Winners Announcement - ESGO 2025 congress

ESGO eAcademy, Nicole Concin, 4151651

IJGC Awards ESGO 2025

ESGO eAcademy, Pedro Ramirez, 4151650

Lifetime Achievement Award: Introduction of the Award Winner ESGO 2025

ESGO eAcademy, Luis Chiva, 4151649

Welcome speeches ESGO 2025 congress

ESGO eAcademy, Isabelle Ray-Coquard, 4151647

Welcome speech ESGO 2025 congress

ESGO eAcademy, Anna Fagotti, 4151646

Pelvic Anterior Exenteration For Cervical Cancer Recurrence By Robotic Approach

ESGO eAcademy, Marc Zarzoso Gimenez, 4151639

How to Improve Patient – Doctor Communication

ESGO eAcademy, Annette Hasenburg, 4151645

Oligometastatic Disease in Gynecological Malignancies: To Irradiate or Not to Irradiate?

ESGO eAcademy, Gabriella Macchia, 4151642

Radical Colpohysterectomy : A Step-By-Step Video Guide Of A Single-Patient Case

ESGO eAcademy, Marie Bouabdallah, 4151638

Selective Systematic Nerve-Sparing Type C2 Radical Hysterectomy

ESGO eAcademy, Ilker Selcuk, 4151637

Patient Participation in Clinical Trials

ESGO eAcademy, Joachim Weis, 4151644

Overview on Endometrial and Vaginal Cancer

ESGO eAcademy, Remi Nout, 4151641

Spiralized Rectus Abdominis Muscle (SRAM) Flap For Total Vaginal Reconstruction: Case Report Of A Novel Technique

ESGO eAcademy, Oytun Turkkan, 4151636

Shared Decision Making - How to Survive

ESGO eAcademy, Elisabeth Andritsch, 4151643

Overview on Cervical and Vulvar Cancer

ESGO eAcademy, Alina Sturdza, 4151640

Laterally Extended Pelvic Resection

ESGO eAcademy, Giulio Ricotta, 4151635

Impact of Adjuvant Radiotherapy on Fatigue in Gynaecological Cancer Patients: A 20-Year Single Institutional Experience in 501 Patients

ESGO eAcademy, Paolo Bonome, 4151634

ESGO Quiz results

ESGO eAcademy, Marie Plante, 4152024

Impact Of An Enhanced Recovery After Surgery Program On Outcomes In Elderly Patients Undergoing Open Gynecologic Oncology Surgery

ESGO eAcademy, Maria Iniesta, 4151633

Predicting Lymph Node Metastasis In Operable Cervical Cancer Patients: Can We Identify Patients At Risk For Dual Surgical And Radiotherapeutic Treatments?

ESGO eAcademy, Nuria Agusti Garcia, 4151632

The Role of Molecular (and Non-molecular) Biomarkers in Tayloring Endometrial Cancer Medical Treatment in Advanced and Metastatic Disease

ESGO eAcademy, Domenica Lorusso, 4151627

Patterns, Risk Factors And The Impact Of Concomitant Cisplatin On Distant Metastasis In Locally Advanced Cervical Cancer – An EMBRACE I Analysis

ESGO eAcademy, Johannes Knoth, 4151631

Minimally Invasive Surgery for Low-risk Cervical Cancer: Not So Fast! (Against MIS)

ESGO eAcademy, Pedro Ramirez, 4151624

Radical Trachelectomy For Early Stage Cervical Cancer In The Netherlands: A Nationwide Cohort Study On Long-Term Oncologic, Fertility, And Obstetric Outcomes.

ESGO eAcademy, Yaël Stroeken, 4151630

Is There a Role for Molecular (and other) Biomarkers in Guiding Surgical Treatment in Endometrial Cancer?

ESGO eAcademy, Philipp Harter, 4151626

Uncovering The Disease Biology Of HPV Persistence - An Examination Of Proteomics In The UK Biobank

ESGO eAcademy, Blanche Francheterre, 4151629

Early-STage CERvical CaNcer Undergoing For FertilItY-Sparing Approach: Long-Term Outcomes From The ETERNITY Project

ESGO eAcademy, Giorgio Bogani, 4151628

Predictive and Prognostic Biomarkers and It’s Therapeutic Role in Early Stage

ESGO eAcademy, Antonio Gonzalez Martin, 4151625

Why Not Offer the Best Approach to Patients with Low-risk Cervical Cancer? (For MIS)

ESGO eAcademy, René Pareja, 4151623

Uterine Sarcoma Mobile App Update

ESGO eAcademy, Enora Laas, 4151622

Gynaecological Cancers at AYA Age: Consequences on Daily Life at the Short and Long-term

ESGO eAcademy, Winette van der Graaf, 4151618

The Role of the PAP Test in the Prevention of Ovarian and Endometrial Cancer

ESGO eAcademy, Silvia Cabrera, 4151613

How Molecular Analysis Can Help Managing Uterine Sarcoma Patients - A Practical Approach with Real Life Cases

ESGO eAcademy, Sabrina Croce, 4151620

Challenges when Ovarian Cancer Complicates Pregnancy

ESGO eAcademy, Frederic Amant, 4151617

ESGO Consensus Statement on Prevention, Risk Reduction Strategies and Management of Women with Hereditary Predisposition to Ovarian Cancer

ESGO eAcademy, Claudia Marchetti, 4151612

Role of Surgery in Uterine Sarcomas: ESGO Recommendations

ESGO eAcademy, Ignacio Zapardiel, 4151619

Cervical Cancer in AYA Patients

ESGO eAcademy, Zoltan Novak, 4151616

ESGO Consensus Statement on Endometrial Cancer Prevention, Risk Reduction Strategies, and Management of Women with Lynch Syndrome

ESGO eAcademy, Murat Gultekin, 4151611

Best Oral session: Discussant - why is quality of life important?

ESGO eAcademy, Jalid Sehouli, 4151603

Fertility Sparing Management in Gestational Trophoblastic Disease

ESGO eAcademy, Nikolaos Thomakos, 4151606

Health-Related Quality Of Life After Risk-Reducing Hysterectomy: A Cross-Sectional Study Of Women With Lynch Syndrome

ESGO eAcademy, Sam Oxley, 4151602